Identification and treatment of APS renal involvement

Lupus

Volumn 23, Issue 12, 2014, Pages 1276-1278

  Tektonidou, M G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

antiphospholipid antibody associated nephropathy; Antiphospholipid syndrome; renal manifestations; thrombotic microangiopathy

Indexed keywords

ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; HEMATURIA; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INFARCTION; KIDNEY VEIN THROMBOSIS; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATHOGENESIS; PROGNOSIS; PROTEINURIA; RECANALIZATION; RENAL ARTERY THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; BLOOD; COMPLICATION; KIDNEY DISEASES;

PHOSPHOLIPID ANTIBODY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; KIDNEY DISEASES; PROGNOSIS;

EID: 84908689682     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314538687     Document Type: Conference Paper

References (12)

1. Tektonidou MG. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin Rev Allergy Immunol. 2009 ; 36: 131-140
2. Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol. 1992 ; 19: 1181-1185
3. Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999 ; 10: 507-518
4. Daugas E, Nochy D, Huong DL, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol. 2002 ; 13: 42-52
5. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long-term outcome. Arthritis Rheum. 2004 ; 50: 2569-2579
6. Silvariño R, Sant F, Espinosa G, et al. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Lupus. 2011 ; 20: 721-729
7. Zheng H, Chen Y, Ao W, et al. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: A prospective study of 124 cases. Arthritis Res Ther. 2009 ; 1: R93 - R93
8. Fakhouri F, Noël LH, Zuber J, et al. The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis. 2003 ; 41: 1205-1211
9. Seshan SV, Franzke CW, Redecha P, Monestier M, Mackman N, Girardi G. Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood. 2009 ; 114: 1675-1683
10. Wu LH, Yu F, Tan Y, et al. Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int. 2013 ; 83: 715-723
11. Erkan D, Vega J, Ramón G, Kozora E, Lockshin MD. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum. 2013 ; 65: 464-471
12. Safa K, Logan MS, Batal I, Gabardi S, Rennke HG, Abdi R. Eculizumab for drug-induced de novo post-transplantation thrombotic microangiopathy: A case report. Clin Nephrol. Epub ahead of print 5 February 2014.